Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: DKK3 for Prognosis and Monitoring of GFR Decline in Heart Failure
A completed clinical trial assessing the biomarker DKK3 for prognosis and monitoring GFR decline in heart failure patients, including those …
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Effect of Mindfulness-based Applied to Hemodialysis Patients on Psychosocial Adaptation [NA]
The study completed an evaluation of a mindfulness-based program for patients undergoing hemodialysis to assess its effect on psychosocial a…
-
CLINICAL_TRIALS withdrawal · 2024-05-07Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus [Phase 3]
Phase 3 trial evaluating difelikefalin for pruritus in advanced chronic kidney disease was terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus [Phase 3]
A Phase 3 trial evaluating difelikefalin (CR845) for pruritus in advanced chronic kidney disease has been terminated.
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes? [Phase 2]
Phase 2 clinical trial update evaluating normothermic machine perfusion for kidney transplant outcomes; the study is currently active but no…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Effects of Different Inspiratory Muscle Training Protocols in Patients With Chronic Kidney Disease [NA]
This update reports on a completed trial evaluating how different inspiratory muscle training protocols affect patients with chronic kidney …
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Enhancing Fluid Transfer Through the Skin, by Increased Sweat Rate, on Hemodialysis Patients [NA]
Clinical trial by AquaPass Medical Ltd. on enhancing fluid transfer through the skin via increased sweat rate in hemodialysis patients has c…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Effect of Hormone Therapy on Renal Function
The document notes the completion of a clinical trial evaluating the impact of gender-affirming hormone therapy on renal function in individ…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients [NA]
This clinical trial is evaluating whether the SGLT2 inhibitor dapagliflozin can delay the decline of renal function in patients on peritonea…
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Cardiovascular Disease in Patients With Chronic Kidney Disease: Polish Kidney- Heart Project
Clinical trial update indicates ongoing recruitment for the Polish Kidney-Heart Project. The study investigates cardiovascular disease in pa…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Role of Serum ADAM 17 (A Disintegrin And Metalloprotease 17) and Caspase 3 in Patients With Chronic Kidney Disease
This clinical trial investigates the roles of serum ADAM17 and caspase-3 as biomarkers in chronic kidney disease. The study status is not ye…
-
FDA approval · 2024-04-30FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for sevelamer carbonate filed by Aurobindo Pharma Limited, enabling a supplemental approval for …
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: The PRO-FUTURE Project
A ClinicalTrials.gov entry for the PRO-FUTURE Project from the University of Campania Luigi Vanvitelli, currently recruiting participants fo…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: SGLT2 Inhibitors and Treatment of Heart Failure in Severe Renal Insufficiency [Phase 4]
A Phase 4 trial evaluating SGLT2 inhibitors for heart failure with reduced ejection fraction in patients with chronic kidney disease has bee…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Ketoacid Analogues Intradialytic Effect on Inflammation [NA]
Clinical trial update describing a study on the intradialytic anti-inflammatory effects of ketoacid analogue therapy in patients undergoing …
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT [Phase 4]
Phase 4 trial evaluating the efficacy and safety of cinacalcet on calcium, phosphorus, and iPTH levels in patients with secondary hyperparat…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: The Effect of Acceptance and Commitment Therapy in Patients With Chronic Renal Failure [NA]
A clinical trial evaluating Acceptance and Commitment Therapy in patients with chronic kidney disease is currently active but not recruiting…
-
FDA approval · 2024-04-25FDA Approved: SEVELAMER CARBONATE — Original Application (NorthStar RxLLC)
FDA approved NorthStar RxLLC's generic sevelamer carbonate (ANDA 207291) for the treatment of hyperphosphatemia in adults with chronic kidne…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Chronic Arterial Disease, Quality of Life and Mortality in Chronic Kidney Injury
This entry describes an active-not-recruiting clinical trial led by Turku University Hospital. The study investigates the relationship betwe…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Cardiovascular-Renal Adverse Prognosis Assessment System for Coronary Heart Disease With Chronic Kidney Disease Based on Metabolomics
A metabolomics-based Cardiovascular-Renal Adverse Prognosis Assessment System is being studied for prognosis in patients with coronary heart…
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease [Phase 4]
Phase 4 trial investigating parathyroid hormone for treatment of adynamic bone disorder in chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin. [Phase 4]
A decentralized N=1 trial evaluates individual response to dapagliflozin in type 2 diabetes patients, completed phase 4.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects [Phase 3]
A Phase 3 trial evaluating pharmacokinetics and safety of MB-102 (Relmapirazin) and the MediBeacon transdermal GFR measurement system in nor…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Kidney Coordinated Health Management Partnership [NA]
The Kidney Coordinated Health Management Partnership trial for chronic kidney disease has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis [Phase 3]
Phase 3 trial evaluating ferric citrate for treating hyperphosphatemia in patients with chronic kidney disease on hemodialysis has completed…